Skip to main content
Year archive

Genmab — 2020 filings

All 167 regulatory filings released by Genmab (GMAB) in 2020, sourced directly from the official regulator.

167 Filings
2020 Period
2020 filings (167)
Filing Released Lang
6-K
Regulatory Filings
2020-12-21 English
6-K
Regulatory Filings
2020-12-15 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing
2020-12-15 English
Director's Dealing 2020
Director's Dealing
2020-12-15 English
6-K
Regulatory Filings
2020-11-24 English
Genmab Announces Enapotamab Vedotin Update
Regulatory Filings
2020-11-24 English
Regulatory Filings 2020
Regulatory Filings
2020-11-24 English
6-K
Regulatory Filings
2020-11-12 English
6-K
Regulatory Filings
2020-11-10 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2020-11-10 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2020-11-10 English
6-K
Regulatory Filings
2020-11-05 English
Regulatory Filings 2020
Regulatory Filings
2020-11-05 English
Genmab Announces Phase 3 Study Evaluating Epcoritamab in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma
Regulatory Filings
2020-11-05 English
6-K
Regulatory Filings
2020-11-04 English
Genmab Announces IFM, HOVON and Janssen Achieve Positive Topline Results in Second Part of Phase 3 CASSIOPEIA Study of Daratumumab in Multiple Myeloma at Pre-planned Interim Analysis
Regulatory Filings
2020-10-21 English
Regulatory Filings 2020
Regulatory Filings
2020-10-21 English
6-K Filing
Regulatory Filings
2020-10-21 English
6-K
Regulatory Filings
2020-10-15 English
6-K
Regulatory Filings
2020-10-14 English
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2020
Earnings Release Q3 2020
2020-10-13 English
Earnings Release 2020
Earnings Release Q3 2020
2020-10-13 English
6-K
Regulatory Filings
2020-10-07 English
6-K
Regulatory Filings
2020-09-30 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing
2020-09-30 English
Director's Dealing 2020
Director's Dealing
2020-09-30 English
6-K
Regulatory Filings
2020-09-30 English
6-K
Regulatory Filings
2020-09-29 English
6-K
Regulatory Filings
2020-09-29 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing
2020-09-29 English
Director's Dealing 2020
Director's Dealing
2020-09-29 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2020-09-29 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2020-09-29 English
6-K
Regulatory Filings
2020-09-22 English
Genmab Commences Binding Arbitration of Two Matters Under License Agreement with Janssen
Regulatory Filings
2020-09-22 English
Legal Proceedings Report 2020
Legal Proceedings Report
2020-09-22 English
6-K
Regulatory Filings
2020-08-20 English
6-K
Regulatory Filings
2020-08-20 English
Genmab Announces Janssen Granted U.S. FDA Approval for DARZALEX® (daratumumab) in Combination with Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma
Regulatory Filings
2020-08-20 English
Regulatory Filings 2020
Regulatory Filings
2020-08-20 English
Regulatory Filings 2020
Regulatory Filings
2020-08-20 English
Genmab Announces Plan to Transition Arzerra® (ofatumumab) to an Oncology Access Program for Chronic Lymphocytic Leukemia Patients in the U.S.
Regulatory Filings
2020-08-20 English
6-K
Regulatory Filings
2020-08-20 English
U.S. FDA Approves Kesimpta® (ofatumumab) in Relapsing Multiple Sclerosis
Regulatory Filings
2020-08-20 English
Regulatory Filings 2020
Regulatory Filings
2020-08-20 English
6-K
Regulatory Filings
2020-08-19 English
6-K
Regulatory Filings
2020-08-18 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2020-08-18 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2020-08-18 English
6-K
Regulatory Filings
2020-08-12 English
Genmab Announces Financial Results for the First Half of 2020
Report Publication Announcement H1 2020
2020-08-12 English
Interim / Quarterly Report 2020
Interim / Quarterly Report H1 2020
2020-08-12 English
Interim / Quarterly Report 2020
Interim / Quarterly Report H1 2020
2020-08-12 English
6-K
Regulatory Filings
2020-07-31 English
Genmab Announces European Myeloma Network and Janssen Achieve Positive Topline Results from Phase 3 APOLLO Study of Daratumumab in Combination with Pomalidomide and Dexamethasone in Relapsed or Refrac
Regulatory Filings
2020-07-31 English
Regulatory Filings 2020
Regulatory Filings
2020-07-31 English
6-K
Regulatory Filings
2020-07-20 English
Major Shareholder Announcement
Major Shareholding Notification
2020-07-20 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-07-20 English
Genmab Announces Net Sales of DARZALEX® for the Second Quarter of 2020
Earnings Release Q2 2020
2020-07-16 English
Earnings Release 2020
Earnings Release Q2 2020
2020-07-16 English
6-K Filing
Regulatory Filings
2020-07-16 English
6-K
Regulatory Filings
2020-07-07 English
Major Shareholder Announcement
Major Shareholding Notification
2020-07-07 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-07-07 English
6-K
Regulatory Filings
2020-07-06 English
6-K Filing
Regulatory Filings
2020-07-06 English
Major Shareholder Announcement
Major Shareholding Notification
2020-07-03 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-07-03 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-07-03 English
Major Shareholder Announcement
Major Shareholding Notification
2020-07-03 English
6-K Filing
Regulatory Filings
2020-07-01 English
6-K
Regulatory Filings
2020-06-30 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2020-06-30 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2020-06-30 English
6-K
Regulatory Filings
2020-06-30 English
Genmab Announces Very Favorable Topline Results from Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer
Regulatory Filings
2020-06-29 English
Regulatory Filings 2020
Regulatory Filings
2020-06-29 English
6-K
Regulatory Filings
2020-06-11 English
6-K
Regulatory Filings
2020-06-10 English
Genmab and AbbVie Announce Broad Oncology Collaboration
Regulatory Filings
2020-06-10 English
Regulatory Filings 2020
Regulatory Filings
2020-06-10 English
6-K
Regulatory Filings
2020-06-04 English
Genmab Announces European Marketing Authorization for the Subcutaneous Formulation of DARZALEX® (daratumumab) for the Treatment of Patients with Multiple Myeloma
Regulatory Filings
2020-06-04 English
Regulatory Filings 2020
Regulatory Filings
2020-06-04 English
6-K
Regulatory Filings
2020-06-03 English
6-K
Regulatory Filings
2020-05-28 English
Genmab Announces Positive Topline Results in Phase III ANDROMEDA Study of Daratumumab in Light-chain (AL) Amyloidosis
Regulatory Filings
2020-05-28 English
Regulatory Filings 2020
Regulatory Filings
2020-05-28 English
6-K
Regulatory Filings
2020-05-13 English
6-K
Regulatory Filings
2020-05-12 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2020-05-12 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2020-05-12 English
6-K
Regulatory Filings
2020-05-06 English
6-K
Regulatory Filings
2020-05-01 English
Genmab Announces U.S. FDA Approval of Subcutaneous Formulation of Daratumumab, DARZALEX FASPRO™ (daratumumab and hyaluronidase-fihj), for the Treatment of Patients with Multiple Myeloma
Regulatory Filings
2020-05-01 English
Regulatory Filings 2020
Regulatory Filings
2020-05-01 English
6-K
Regulatory Filings
2020-04-30 English
CHMP Issues Positive Opinion Recommending Subcutaneous Formulation of Daratumumab for the Treatment of Patients with Multiple Myeloma
Regulatory Filings
2020-04-30 English
Regulatory Filings 2020
Regulatory Filings
2020-04-30 English
6-K
Regulatory Filings
2020-04-14 English
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2020
Earnings Release Q1 2020
2020-04-14 English
Earnings Release 2020
Earnings Release Q1 2020
2020-04-14 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing
2020-04-01 English
6-K
Regulatory Filings
2020-04-01 English
Director's Dealing 2020
Director's Dealing
2020-04-01 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing
2020-04-01 English
6-K
Regulatory Filings
2020-04-01 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2020-03-31 English
6-K
Regulatory Filings
2020-03-31 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2020-03-31 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2020-03-31 English
6-K
Regulatory Filings
2020-03-31 English
20-F
Annual Report FY 2019
2020-03-30 English
6-K
Regulatory Filings
2020-03-26 English
Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
Director's Dealing
2020-03-26 English
Director's Dealing 2020
Director's Dealing
2020-03-26 English
Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
Director's Dealing
2020-03-26 English
Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to the New Member of the Board of Directors and a New Member of Management, and Grant of Restricted Stock Units an
AGM Information
2020-03-26 English
6-K
Regulatory Filings
2020-03-26 English
Passing of Genmab A/S’ Annual General Meeting
AGM Information
2020-03-26 English
6-K
Regulatory Filings
2020-03-24 English
6-K
Regulatory Filings
2020-03-10 English
Genmab Announces Appointment of Anthony Mancini to Newly Created Position of Chief Operating Officer
Board/Management Information
2020-03-10 English
Board/Management Information 2020
Board/Management Information
2020-03-10 English
Genmab Announces Appointment of Anthony Mancini to Newly Created Position of Chief Operating Officer
Board/Management Information
2020-03-10 English
6-K
Regulatory Filings
2020-02-27 English
Notice to Convene the Annual General Meeting of Genmab A/S
AGM Information
2020-02-27 English
6-K
Regulatory Filings
2020-02-26 English
6-K
Regulatory Filings
2020-02-26 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing
2020-02-26 English
Director's Dealing 2020
Director's Dealing
2020-02-26 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing
2020-02-26 English
6-K
Regulatory Filings
2020-02-25 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing
2020-02-25 English
Director's Dealing 2020
Director's Dealing
2020-02-25 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing
2020-02-25 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2020-02-25 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2020-02-25 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2020-02-25 English
6-K
Regulatory Filings
2020-02-21 English
Genmab Board of Directors Chairman to Step Down
Board/Management Information
2020-02-21 English
Board/Management Information 2020
Board/Management Information
2020-02-21 English
Genmab Board of Directors Chairman to Step Down
AGM Information
2020-02-21 English
Genmab Publishes 2019 Annual Report
Report Publication Announcement
2020-02-19 English
Annual Report 2019
Annual Report FY 2019
2020-02-19 English
Genmab Publishes 2019 Annual Report
Earnings Release FY 2019
2020-02-19 English
Report Publication Announcement 2020
Report Publication Announcement
2020-02-19 English
6-K Filing
Regulatory Filings
2020-02-19 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-07 English
Director's Dealing 2020
Director's Dealing
2020-01-28 English
6-K
Regulatory Filings
2020-01-22 English
Genmab Announces 2019 Net Sales Figures for DARZALEX® (daratumumab) and Achievement of USD 150 Million Sales Milestone in DARZALEX Collaboration with Janssen
Earnings Release FY 2019
2020-01-22 English
Earnings Release 2019
Earnings Release FY 2019
2020-01-22 English
Genmab Announces 2019 Net Sales Figures for DARZALEX® (daratumumab) and Achievement of USD 150 Million Sales Milestone in DARZALEX Collaboration with Janssen
Earnings Release FY 2019
2020-01-22 English
6-K
Regulatory Filings
2020-01-21 English
Genmab Announces European Marketing Authorization for DARZALEX® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma
Regulatory Filings
2020-01-20 English
Regulatory Filings 2020
Regulatory Filings
2020-01-20 English
Genmab Announces European Marketing Authorization for DARZALEX® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma
Regulatory Filings
2020-01-20 English
6-K
Regulatory Filings
2020-01-02 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing
2020-01-02 English
Director's Dealing 2020
Director's Dealing
2020-01-02 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing
2020-01-02 English
6-K
Regulatory Filings
2020-01-02 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing
2020-01-02 English
Director's Dealing 2020
Director's Dealing
2020-01-02 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing
2020-01-02 English